BCN PEPTIDES

  • COMPANY
  • GENERIC PEPTIDES
  • CUSTOM SYNTHESIS
  • PIPELINE
  • EVENTS & NEWS
  • FIND US

NEWS


  • 2020
  • April
  • 2019
  • September
  • March
  • 2018
  • December
  • 2017
  • April
  • March
  • 2016
  • September
  • 2015
  • November
  • January
  • 2014
  • December
  • October
  • May
  • April
  • 2013
  • October
  • July
  • February
  • 2012
  • April
  • 2011
  • September
  • BCN PEPTIDES and GENEPEP form Strategic Alliance

    October 17, 2013


    BCN PEPTIDES and GENEPEP have formed a strategic partnership to extend both companies capabilities towards synthetic peptides process development and manufacturing services on behalf of their clients.

    Press release Genepep-BCN

  • New EU-funded consortium to develop personalized cancer vaccines

    July 4, 2013


    p6agzkhb2h

  • Eurocondor Consortium Starts Clinical trial for Diabetic Retinopathy

    February 14, 2013


    A clinical trial to evaluate a new therapeutic treatment using eye drops for the early stages of diabetic retinopathy started this week, researchers announced. A group of leading European ophthalmologists, endocrinologists and researchers have gathered together with BCN Peptides (a biopharmaceutical SME) under EUROCONDOR, the European Consortium on the early treatment of diabetic retinopathy, and will conduct the clinical trial in 11 clinical centres across the EU. Press release EUROCONDOR



  • BCN Peptides S.A. Poligon Industrial Els Vinyets-Els Fogars II
    08777 Sant Quintí de Mediona, Barcelona - Spain

    Tel. +34 93 819 13 99     Fax. +34 93 826 49 09
    info@bcnpeptides.com

    • careers
    • privacy
    • legal note
    • quality and environment policy